Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Earum Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Friday, 14th July, 2023 at 11:00 am at the Registered Office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola, Ahmedabad - 380060, to discuss and consider: The proposal for Buyback of Equity Shares of the Company, the proposal to recommend the declaration of Final Dividend for the F.Y. 2022-23, the proposal of Issue of Bonus Equity Shares to the existing equity Shareholders of the Company, the proposal of sub-division of equity shares of the Company and to finalize the date, day, time and venue of Annual General Meeting of shareholders for the F.Y. 2022-23.
The above information is a part of company’s filings submitted to BSE.
